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Production of genome-edited animals using germline-
competent cells and genetic modification tools has pro-
vided opportunities for investigation of biological mechan-
isms in various organisms. The recently reported pro-
grammed genome editing technology that can induce 
gene modification at a target locus in an efficient and pre-
cise manner facilitates establishment of animal models. In 
this regard, the demand for genome-edited avian species, 
which are some of the most suitable model animals due to 
their unique embryonic development, has also increased. 
Furthermore, germline chimera production through long-
term culture of chicken primordial germ cells (PGCs) has 
facilitated research on production of genome-edited 
chickens. Thus, use of avian germline modification is 
promising for development of novel avian models for re-
search of disease control and various biological mechan-
isms. Here, we discuss recent progress in genome modifi-
cation technology in avian species and its applications 





Advances in biotechnology have enhanced our understanding 
of biological mechanisms at the molecular level. In particular, 
genome modification and engineering technology have contri-
buted to numerous fields, including agriculture and medicine, 
as well as basic research. Genome modification and engineer-
ing are based on insertion, deletion or replacement of genes to 
alter the genetic information. This biotechnology can be applied 
to alter the genome of various cell types, including somatic, 
pluripotent, and germline competent cells such as sperm, ova 
and fertilized eggs, which transmit genetic information to the 
next generation. Therefore, germline modification and engi-
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neering enables production of genome-edited organisms. The 
primary role of genome-edited organisms is in studying biologi-
cal processes in developmental biology (McMahon et al., 2012). 
In agriculture, genome-edited organisms have been developed 
for environmental threat-resistance, production of functional 
proteins, increasing nutritional value and improving yields, as 
well as unveiling biological mechanisms. Therefore, positive 
economic, academic and environmental effects of genome-
edited livestock and plants have been reported (Tan et al., 
2012). Due to completion of genome sequencing projects, the 
need for production of customized germline modification tech-
nology in diverse organisms has increased (Veeramah and 
Hammer, 2014). In the last 20 years, much effort has focused 
on germline modification in avian species, because aves have 
potential advantages in biotechnology as an animal model due 
to their unique embryonic development (Han, 2009). In particu-
lar, their reproductive characteristics, such as a relatively short 
reproductive cycle and laying over 300 eggs annually, enhance 
their suitability for this research area. Therefore, here we will 
introduce recent progress in, and discuss future strategies for, 
germline genome modification and engineering technology in 
avian species. 
 
GERMLINE COMPETENT CELLS IN AVIAN  
BIOTECHNOLOGY  
 
Germline competent cells are a unique resource used to 
transmit genetic information to the next generation. These in-
clude germline cell lines established by in vitro culture, as well 
as endogenous germline cells (Han et al., 2015). Since modifi-
cation of germline competent cells mediated by genome mod-
ification and engineering technology can facilitate production of 
genome-edited organisms, this technology has been widely 
used in various areas of biology. Following the first report of 
genetically modified bacteria in 1973 (Cohen et al., 1973), sev-
eral organisms with genome editing achieved via the ger-
mline—including roundworm, fruit fly, zebrafish and mouse—
have been reported. These organisms have been used in basic 
research, such as for identification of specific gene functions, as 
well as in applied science, such as for disease control and 
mass production of functional proteins (Kaletta and Hengartner, 
2006; Lieschke and Currie, 2007; Vecchio, 2015; White et al., 
2013a; 2013b). In particular, embryonic stem cells (ESC) with 
germline competency have been utilized for production of ge-
nome-edited animals. Also, induced pluripotent stem cells 
(iPSC) have been used widely in regenerative medicine 
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In avian species, several types of germline competent cell 
have been introduced. Chickens lay eggs composed of 40,000-
60,000 cells, known as stage X blastoderms, in which the cells 
actively proliferate following incubation under optimal conditions 
(Eyal-Giladi and Kochav, 1976). A number of researchers have 
suggested that blastodermal cells at stage X maintain an undif-
ferentiated status similar to mammalian ESCs derived from 
blastocysts. However, the germline transmission efficiency of 
blastodermal cells transplanted into stage X recipient embryos 
was relatively low (0.003-42.5%), despite efforts to increase it, 
such as gamma-ray irradiation or short-term culture of the blas-
todermal cells (Carsience et al., 1993; Pain et al., 1996; Petitte 
et al., 1990). 
To overcome the low germline transmission efficiency of 
blastodermal cells, primordial germ cells (PGCs), the precur-
sors to germ cells, derived from various embryonic stages have 
been used in avian species (Chang et al., 1997; Han et al., 
2002; Naito et al., 1994; Ono et al., 1998; Park et al., 2003a; 
2003b; Tajima et al., 1993). Avian PGCs have a unique devel-
opment system in terms of origin, specification, proliferation, 
and differentiation (Tsunekawa et al., 2000). Avian PGCs are 
dispersed at stage X immediately after oviposition and move to 
the germinal crescent at Hamburger and Hamilton (HH) stage 4 
(Hamburger and Hamilton, 1992). Then, the PGCs enter the 
circulation via extra-embryonic blood vessels until settling in 
embryonic gonads at HH stage 17 (Fig. 1) (Nieuwkoop and 
Sutasurya, 1979). Previous works reported that PGCs isolated 
from each developmental stage show higher germline trans-
mission efficiency (11.3-95.8%) than that of blastodermal cells 
when introduced into the bloodstream of recipient embryos 
(Naito et al., 1994; Tajima et al., 1993).  
Testicular cells also have germline competency in avian spe-
cies. The seminiferous tubules of recipient roosters trans-
planted with testicular cells produced donor-testicular cell-
derived chicks. This system is considered an effective method 
for germline transmission because of the reduced time required 
for production of the next generation. However, it showed low 
germline transmission efficiency (0.4-0.9%) (Lee et al., 2006). 
Therefore, technologies that can enhance germline transmis-
sion efficiency—such as elimination of recipient germ cells or 
purification and establishment of germline competent cell popu-
lations from donor roosters—are required (Kanatsu-Shinohara 
et al., 2012; Lim et al., 2014; Nakamura et al., 2010; Park et al., 
2010). 
 
ESTABLISHMENT OF AVIAN GERMLINE COMPETENT 
CELL LINES  
 
Long-term in vitro culture of germline competent cells without 
loss of their germline transmission ability is essential for ger-
mline modification and its applications, as is isolation and 
transplantation of the cells themselves. The technology not only 
enhances understanding of the specific mechanisms of germ 
cell maintenance, development and differentiation but also 
provides sources for production of genome-edited animals. In 
vitro proliferation of germline competent cells—including ESCs, 
embryonic germ cells (EGCs), PGCs and spermatogonial stem 
cell—in mammals has been reported, and these cells have 
been widely used in modern biology (Evans and Kaufman, 
1981; Kanatsu-Shinohara et al., 2003; Matsui et al., 1992; Res-
nick et al., 1992). 
In avian species, trials of long-term in vitro culture systems 
have been reported. ESCs derived from stage X blastodermal 
cells using stem cell factor, fibroblast growth factor (FGF) and 
leukemia inhibitory factor were established. The cells showed 
expression of pluripotency marker genes, including POU do-
main class 5 transcription factor 3 (POUV), SRY (sex determin-
ing region Y)-box 2 (SOX2), Nanog homeobox (NANOG), and 
Kruppel-like factor and the ability to differentiate into three germ 
layers, similar to murine ESCs, although the cells showed low 
germline transmission efficiency (Jean et al., 2013; Pain et al., 
1996; Petitte et al., 2004).  
In vitro culture of EGCs derived from gonadal PGCs has also 
been investigated. We reported previously successful estab-
lishment of EGCs derived from gonadal PGCs of HH stage 28 
embryos in vitro; the cells showed several ESC characteris-
tics—including migration, Periodic Acid–Schiff (PAS) and Stage-
Specific Embryonic Antigen-1 (SSEA-1) antibody reactivity and 
Fig. 1. Chicken PGC migration and settlement during embryonic development. Avian PGCs are dispersed at stage X and move to the germin-
al crescent at HH stage 4. They then undergo circulation via extra-embryonic blood vessels until settlement in embryonic gonads at HH stage
17. The figure is modified from Nieuwkoop and Sutasurya(1979). 
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germline competency—when transplanted into recipient em-
bryos (Park et al., 2003a). The cells showed higher germline 
transmission capacity (1.5-25.0%) than that of ESCs derived 
from stage X blastodermal cells. 
Both ESCs and EGCs, however, still showed low germline 
transmission efficiency. To overcome this problem, researchers 
used in vitro PGC cultures. Park et al. (2003b) reported that 
PGCs isolated from embryonic gonads (stage 28) and cultured 
for 5 or 10 days showed relatively high germline competency 
(0.9-56.5%). Recently, McGrew and our group reported a 
chicken PGC in vitro culture system using basic FGF medium. 
The PGCs proliferated in an unlimited manner in vitro, ex-
pressed germness-related genes—including chicken vasa 
homolog, deleted in azoospermia-like, POUV, SOX2, NANOG 
and v-myc avian myelocytomatosis viral oncogene homolog (C-
MYC)—and exhibited telomerase activity and unique migratory 
characteristics when injected into recipient embryos. Further-
more, compared with other germline competent cell lines, they 
showed markedly higher germline transmission ability when 
transplanted into recipient embryos (12.5-82.6%) (Fig. 2) (Choi 
et al., 2010; Macdonald et al., 2010).  
 
DIRECT GERM CELL ENGINEERING FOR GERMLINE 
MODIFICATION 
 
Genome modification of germ cells based on culture systems 
has provided opportunities not only to investigate the functions 
of specific genes in germ cells but also to develop novel animal 
models for human disease (Saitou and Yamaji, 2012). Devel-
opment of disease models, especially for cancer, can provide 
enhanced understanding of the mechanisms of proliferation, 
metastasis and apoptosis of cancer cells (Cheon and Orsulic, 
2011). In addition, mass production of pharmaceutical proteins 
in genome-edited organisms mediated by direct germ cell engi-
neering has considerable economic and societal benefits (Dove, 
2000; Sijmons et al., 1990). 
After development of somatic nuclear cell transfer (SCNT) 
technology in sheep (Wilmut et al., 1997), direct germline mod-
ification using SCNT has been investigated in several organ-
isms for the purposes of efficient farm animal production, mass 
production of drugs, regenerative medicine and conservation of 
genetic resources (Ogura et al., 2013). SCNT is at present the 
most effective method for producing genome-edited animals 
and research into germ cell biology in mammalian species.  
Direct germ cell engineering in avian species focused initially 
on blastodermal cells for production of transgenic animals. After 
the first report of production of transgenic chickens mediated by 
retroviral infection of stage X embryos, production of transgenic 
avians has been based primarily on viral infection systems 
(Kamihira et al., 2009; Lillico et al., 2007; Salter et al., 1986). 
However, genome engineering of blastodermal cells using viral 
infection systems has several limitations, including low germline 
Fig. 2. Schematic representation of germline chimera production using long-term cultured, germline-competent PGCs. Long-term cultured
PGCs derived from Korean Oge (KO) (i/i; black feather) are transplanted into blood vessels of stage 14-17 White Leghorn (WL) embryos (I/I;
white feather). Sexually matured germline chimeras (I and i) are crossed with KO (i/i). Feather color distinguishes donor PGC-derived progeny
(i/i) from the WL/KO hybrid (I/i). 
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transmission ability, silencing of the expression of the inserted 
gene, and unexpected phenomena due to random transgene 
integration (Kamihira et al., 2005; Mizuarai et al., 2001). 
PGCs, which are unipotent and differentiate only into germ 
cells, have been emphasized as an alternative resource for 
germline modification. In 2006, direct germline modification 
mediated by electroporation of linearized DNA into cultured 
chicken blood PGCs was reported. The results suggested that 
PGCs are a promising cell type for germline modification (van 
de Lavoir et al., 2006). Establishment of a long-term culture 
system for chicken PGCs using basic FGF-containing medium 
(Choi et al., 2010; Macdonald et al., 2010) was followed by 
production of transgenic chickens via transplantation of cultured 
PGCs (Macdonald et al., 2012; Park and Han, 2012; Park et al., 
2015). Furthermore, several studies based on long-term PGC 
culture systems have aimed to identify specific genetic and 
epigenetic mechanisms in PGCs, which is difficult in other spe-
cies (Lee et al., 2011; Rengaraj et al., 2011; 2014). 
 
PROGRAMMABLE GENOME EDITING FOR GERMLINE 
MODIFICATION 
 
Despite the efficiency of transgenic technology using long-term 
culture of PGCs in avian species, random integration remains 
limited due to use of transposon vector systems (Macdonald et 
al., 2012; Park and Han, 2012). Therefore, there is a need for 
precise genome targeting. In 2013, homologous recombination-
mediated immunoglobulin gene knockout in chickens was re-
ported; however, the germline transmission efficiency was ex-
tremely low (< 0.002%) (Schusser et al., 2013). Since homolo-
gy-directed repair (HDR) occurs less frequently than nonhomo-
logous end joining (NHEJ) in nature (Mali et al., 2013), promo-
tion of HDR by repression of NHEJ machinery may be an alter-
native method for precise genome replacement mediated by 
homologous recombination (Maruyama et al., 2015). 
On the other hand, our group adopted transcription activator-
like effector nucleases (TALEN), a programmable genome 
editing (PGE) technology, to produce ovalbumin gene knockout 
chicken. TALEN breaks double-stranded genomic DNA and 
induces NHEJ (Christian et al., 2010). NHEJ occurs more fre-
quently than HDR; therefore, TALEN shows higher efficiency in 
terms of genome mutation than that of homologous recombina-
tion mediated genome editing. As expected, the efficiency of 
genome-edited chicken production was improved markedly (< 
10.4%), and precise genome editing was confirmed without 
plasmid residue (Park et al., 2014).  
PGE technologies—including zinc finger nucleases, TALEN 
and clustered regularly interspaced short palindromic re-
peats (CRISPR)-associated protein 9 (CRISPR/Cas9)—are 
versatile tools for genome editing in various organisms (Kim 
and Kim, 2014). Although there are concerns regarding 
induction of off-target mutations than can cause chromo-
somal rearrangements—including deletions, inversions and 
translocations—the specificity of the nucleases has been 
increased based on experimental evidence and computa-











Fig. 3. Applications of genome-edited chickens in avian influenza (AI) resistance and egg protein modification. (A) CRISPR/Cas9 system-
mediated viral RNA recognition and degradation. Transgenic chickens expressing CRISPR/Cas9 elements specifically targeting AI viral RNA
segments exhibit AI resistance. (B) Genome modification and engineering of egg protein-coding genes. Eggs laid by genome-edited chickens
could be used for production of functional proteins. 
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FUTURE STRATEGIES IN AVIAN GERMLINE MODIFICATION 
 
Avian species are needed as model animals as well as indus-
trial resources. However, few genome-edited aves have been 
reported due to the lack of an efficient system that can be ap-
plied to avian species. Recent reports of development of trans-
genic chickens and/or genome-edited chickens showed their 
potential for various applications (Macdonald et al., 2012; Park 
and Han, 2012; Park et al., 2014; 2015; Schusser et al., 2013). 
Therefore, highly efficient and precise genome editing technol-
ogy will maximize the utilization of the chicken as an animal 
model as well as a valuable resource in industry.  
One example is genome-edited avians used for disease 
control. At present, not only global climate change but also 
disease pandemics threaten the lives of wild animals. In par-
ticular, epidemic avian influenza (AI) mediated by migratory 
birds is a major cause of death among avian species, and 
mutations can enable this virus to infect other animals, includ-
ing humans (Schrauwen and Fouchier, 2014). Diverse ap-
proaches have been used to preserve avian genetic re-
sources from potential threats. However, no definitive method 
has been presented. Germline modification and engineering 
represent a novel approach to establish disease-resistant 
avian lines. Indeed, genome-edited chickens expressing 
shRNA specifically targeting viral RNA polymerase activity 
resulted in reduced AI viral transmission (Lyall et al., 2011). 
This suggests germline genome modification of avian species 
to be an alternative method for addressing viral disease pan-
demics. Also, the recently developed CRISPR/Cas9 system, 
which recognizes and cleaves single-stranded RNA (Fig. 3), 
and inducible expression of viral proteins using the piggyBac 
system are expected to be utilized for production of disease-
resistant avian lines (O'Connell et al., 2014; Park and Han, 
2012). Germline modification will be utilized not only for avian 
diseases but also for human diseases, such as cancer. In 
particular, chicken ovarian cancer has histological, morpho-
logical and molecular similarities with human ovarian cancer 
that make it a suitable model for the latter (Hawkridge, 2014). 
Development of novel avian disease models using germline 
modification technology could contribute to our understanding 
of ovarian cancer at the molecular level.  
Another promising application of germline modification is alte-
ration of egg protein composition. Chicken egg white is com-
posed of major proteins—such as ovalbumin, ovotransferrin, 
ovomucoid, ovomucin, and lysozyme—and small quantities of 
bio-functional proteins (Stevens, 1991). Application of PGE 
techniques using germ cell manipulation and transgenic sys-
tems to regulate the composition of egg white enables produc-
tion of protein-modulated eggs. These can have various proper-
ties, such as increased nutrient levels, reduced allergenicity, 
production of high levels of antimicrobial substances, and in-
creased concentrations of bioactive materials (Fig. 3). PGE 
technologies, including TALEN and CRISPR/Cas9, have been 
applied to develop a high-yield egg-bioreactor, which can pro-
duce useful materials by regulating the production of natural 
proteins. Furthermore, many valuable proteins can be pro-
duced using this system; e.g., high-cost growth factors, recom-
binant vaccines, hormones, and industrial materials, such as 
recombinant spider silk-like protein. The combination of tradi-
tional animal farming and the latest biotechnology may yield 




Germline modification will play an essential role in future bio-
technology. Despite the wide range of applications of birds as 
animal models, only a few genome-edited animals have been 
reported to date compared with other species. State-of-the-art 
genome editing technology using long-term cultured PGCs has 
been applied to avian species only recently. Efficient and pre-
cise PGE technologies combined with long-term PGC culture 
systems will open a new era in avian biotechnology and have 
considerable benefits for the poultry industry. 
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